Tsutomu Yagi

This inventor holds 12 USPTO granted patents, plus 5 CIPO patents and 7 EPO patents. Top assignees: Daiichi Sankyo Company, Limited, Daiichi Pharmaceutical Co., Ltd.. Active years: 2005-2014.

USPTO Granted Patents = 12

% Patents Active = 33.3

CIPO Patents = 5

EPO Patents = 7 (Patent Applications = 5)

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 15(Granted Patents)

Location History:

Edogawa-ku, JP (2005 - 2014)
Tokyo, JP (2007 - 2014)

Company Filing History:

7 out of 460

Daiichi Sankyo Company, Limited

patents

5 out of 200

Daiichi Pharmaceutical Co., Ltd.

patents

Years Active: 2005-2014

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8735598 - Method for producing 1-biphenylmethylimidazole compound (2014-05-27),

2. 8686189 - Optically active diamine derivative and process for producing the same (2014-04-01),

3. 8058440 - Process for producing 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid (2011-11-15),

4. 8049006 - 7-membered ring compound and method of production and pharmaceutical application thereof (2011-11-01),

5. 7880005 - Process for producing 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid (2011-02-01),

6. 7678910 - Process for producing 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]Pyridine-2-carboxylic acid (2010-03-16),

7. 7547786 - Process for producing thiazole derivative (2009-06-16),

8. 7217560 - Process for preparation of optically active propoxyaniline derivatives (2007-05-15),

9. 7189847 - Process for producing benzoxazine derivative and production intermediate thereof (2007-03-13),

10. 7126003 - Method for producing 2-azetidinone derivative (2006-10-24),

11. 7087778 - Process for producing benzoxazine derivative and production intermediate thereof (2006-08-08),

12. 6872823 - Process for producing benzoxazine derivative and production intermediate thereof (2005-03-29),

Title: Tsutomu Yagi: Innovator in Pharmaceutical Chemistry

Introduction

Tsutomu Yagi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 12 patents. His work focuses on developing compounds that have therapeutic applications, particularly in the area of blood coagulation and receptor antagonism.

Latest Patents

One of his latest patents is a method for producing a 1-biphenylmethylimidazole compound. This invention provides a method for producing a compound that exhibits superior angiotensin II receptor antagonistic activity. The process involves oxidizing a specific compound using an oxidizing agent in the presence of a radical initiation reagent, followed by a reaction with an ammonia-generating reagent. Another notable patent is for an optically active diamine derivative and the process for producing the same. This invention is aimed at creating intermediates for a compound that inhibits blood coagulation factor Xa, which is crucial for preventing and treating thrombotic diseases.

Career Highlights

Throughout his career, Tsutomu Yagi has worked with notable companies in the pharmaceutical industry, including Daiichi Sankyo Company, Limited and Daiichi Pharmaceutical Co., Ltd. His expertise in the field has allowed him to contribute to various innovative projects and advancements in drug development.

Collaborations

Tsutomu has collaborated with several professionals in his field, including Koji Sato and Kouji Sato. These collaborations have further enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Tsutomu Yagi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant innovator in the industry. His work continues to influence the development of therapeutic agents that address critical health issues.